344 related articles for article (PubMed ID: 14632799)
1. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin.
Niwa Y; Terashima T; Sumi H
Br J Dermatol; 2003 Nov; 149(5):960-7. PubMed ID: 14632799
[TBL] [Abstract][Full Text] [Related]
2. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
3. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
4. Lack of promotion of 7,12-dimethylbenz[a]anthracene-initiated mouse skin carcinogenesis by 1.5 GHz electromagnetic near fields.
Imaida K; Kuzutani K; Wang J; Fujiwara O; Ogiso T; Kato K; Shirai T
Carcinogenesis; 2001 Nov; 22(11):1837-41. PubMed ID: 11698347
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
Yokota K; Gill TJ; Shinozuka H
Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029
[TBL] [Abstract][Full Text] [Related]
7. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of o-Phenylphenol (CAS No. 90-43-7) Alone and with 7,12-Dimethylbenz(a)anthracene (CAS No. 57-97-6) in Swiss CD-1 Mice (Dermal Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1986 Mar; 301():1-141. PubMed ID: 12748705
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoylphorbol-13-acetate and throughout the ontogeny of skin cancer. Part II: Quantitation of glutathione and glutathione disulfide.
Reiners JJ; Kodari E; Cappel RE; Gilbert HF
Carcinogenesis; 1991 Dec; 12(12):2345-52. PubMed ID: 1747938
[TBL] [Abstract][Full Text] [Related]
11. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral administration of ciclosporin A on skin carcinogenesis: a study using the two-stage carcinogenesis protocol in mice.
Yajima Y; Sueki H; Oguro T; Yoshida T; Iijima M
Clin Exp Dermatol; 2008 Jul; 33(4):478-83. PubMed ID: 18498406
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
14. The reverse experiment in two-stage skin carcinogenesis. It cannot be genuinely performed, but when approximated, it is not innocuous.
Iversen OH
APMIS Suppl; 1993; 34():1-96. PubMed ID: 8251199
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020
[TBL] [Abstract][Full Text] [Related]
16. Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-1 mice.
Hennings H; Spangler EF; Shores R; Mitchell P; Devor D; Shamsuddin AK; Elgjo KM; Yuspa SH
Environ Health Perspect; 1986 Sep; 68():69-74. PubMed ID: 3780634
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
18. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
Murphy JE; Morales RE; Scott J; Kupper TS
J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
[TBL] [Abstract][Full Text] [Related]
19. Sodium o-phenylphenate (OPP-Na) promotes skin carcinogenesis in CD-1 female mice initiated with 7,12-dimethylbenz[a]anthracene.
Takahashi M; Sato H; Toyoda K; Furukawa F; Imaida K; Hasegawa R; Hayashi Y
Carcinogenesis; 1989 Jul; 10(7):1163-7. PubMed ID: 2500267
[TBL] [Abstract][Full Text] [Related]
20. Two-stage carcinogenesis in NMRI mice: intravaginal application of 7,12-dimethylbenz[a]anthracene as initiator followed by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.
Goerttler K; Löhrke H; Hesse B
Carcinogenesis; 1980 Aug; 1(8):707-13. PubMed ID: 11272124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
